{"id":447954,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2015-03-26] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:41:14.928000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-8.html?wbdisable=false","snippet":"Notice - Prescription Drug List (PDL): Multiple additions March 26, 2015 Our file number: 15-103382-697 The purpose of this Notice of Amendment is to notify the addition of Dapagliflozin, Deferiprone, Ombitasvir, Dasabuvir, Paritaprevir, Sodium phenylbutyrate, Pradofloxacin and…","rawSnapshotUrl":"/api/snapshots/raw/447954","browseUrl":"https://replay.healtharchive.ca/job-6/20260103154114/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-8.html?wbdisable=false#ha_snapshot=447954","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}